Analysis

Traws Pharma, Inc. (TRAW) Stock Analysis

Traws Pharma, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to TRAW.

websiteTRAW/analysis/TRAW

Traws Pharma, Inc.

Traws Pharma, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to TRAW.

Stock profile

Ticker

TRAW

Asset type

Stock

Market cap

$12.9M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Traws Pharma, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • TRAW primary listing
  • 0T20
  • A40PJ7

Latest Traws Pharma, Inc. news

Traws Pharma Provides Regulatory Update on Influenza Program

NEWTOWN, Pa., June 12, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW, the Company), a clinical-stage biopharmaceutical company developing novel therapies for critica...

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

Private financing of up to $60M offering of common stock (with $10M upfront) and milestone-based warrants expected to support operations into Q1 2027 Tivoxavir marboxil advancin...

Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections

NEWTOWN, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developin...

Traws Pharma Announces Up to $60 Million Private Placement Financing

Financing led by Sirenia Capital Management LP advances Traws Pharma's influenza program through a human challenge trial for tivoxavir marboxil in the United

Research sections

Valuation

Review valuation context for Traws Pharma, Inc..

Future growth

Review future growth context for Traws Pharma, Inc..

Past performance

Review past performance context for Traws Pharma, Inc..

Financial health

Review financial health context for Traws Pharma, Inc..

Dividend

Review dividend context for Traws Pharma, Inc..

Management

Review management context for Traws Pharma, Inc..

Ownership

Review ownership context for Traws Pharma, Inc..

Other information

Review other information context for Traws Pharma, Inc..

Community

Review community context for Traws Pharma, Inc..